Improving
Asthma Patient Outcomes with Community Pharmacist Interventions
Please
read through the following information and click continue.
ACPE Universal Program Number:
207-000-08-143-H01-P and 207-000-08-143-H01-T
Release Date: October 14, 2008
Expiration Date: October 14, 2011
Statement
of Need
In
2005, the Centers for Disease Control and Prevention (CDC) estimated
that currently 22.2 million people were diagnosed with asthma in the
United States. Asthma cannot be prevented or cured. However, asthma can
be controlled. An alarming number of adults and children with asthma
continue to be hospitalized, treated in emergency rooms, or require
other urgent care for their asthma.
A key component of controlling asthma is a proper medical management plan and avoiding asthma "triggers." A very important part of this process is the education of patients about their condition, how to prevent asthma attacks, how to handle asthma attacks when they occur, how to use medications and monitoring devices correctly, and the importance of medication adherence. Pharmacists play a vital role in the improvement of patient education, management and outcomes.
Pharmacist
Learning
Objectives
Upon
successful completion of this activity, the pharmacist should be able
to:
- Define asthma and describe the need for improved patient care for the asthma patient population.
- Explain the classification of asthma and the appropriate NHLBI treatment guidelines.
- Demonstrate appropriate inhaler device and peak flow meter use.
- Discuss effective asthma medication plan development and strategies for medication therapy communication with prescribers.
- Discuss strategies for proper patient education, monitoring, and drug management.
Pharmacy
Technician Learning
Objectives
Upon
successful completion of this activity, the pharmacy technician should
be able
to:
- Define asthma and describe the need for improved patient care for the asthma patient population.
- Demonstrate appropriate inhaler device and peak flow meter use.
- Discuss the technician's role for proper patient education, monitoring and drug management.
Target
Audience
The
target market for this activity is pharmacists and pharmacy technicians.
Instructions
for Participation
To
receive a certificate of completion that indicates your eligibility for
continuing education credit, you must:
- Review the content of the activity.
- Successfully complete the post-test (70% or higher).
- You will have two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee
There
is no fee for this activity.
Accreditation
Pharmacists
NCPA is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
This program will provide 1.5 contact hours (.15 CEUs) of continuing
pharmacy education credit under the number 207-000-08-143-H01-P
and 207-000-08-143-H01-T.
Faculty
Scott
K. Stolte, PharmD (click here to view bio)
Associate Professor and Associate Dean
Academic Affairs
Shenandoah University
Winchester, Virginia
Disclosure
Declaration
It
is the policy of the National Community Pharmacists Association (NCPA)
to ensure independence, balance, objectivity, scientific rigor, and
integrity in all of their continuing education activities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Commercial
Support Statement
Commercial
support provided by AstraZeneca.
 |
Software Requirements
|
PC *Required to view Printable PDF Version |
MAC |